2[1]Guba SC,Fink LM,Fonseca V. Hyperhomocysteinemia an emerging and important risk factor for thromboembolic and cardiovascular disease[J].Am J Clin pathol,1996,106(6):709-722.
3[2]Abby SL,Harris IM,Harris KM,et al. Homocysteine and cardiovasular disease[J].J Am Board Fam Prant,1998,11: 391-398.
4[3]Biasioli S,Schiavone R. Homocysteine as a cardiovascular risk factor[J].Blood Purif,2000,18(3):177-182.
5[4]De Jong SC,Vanden Berg M,Stehouwer CD. Hyperhomocysteinemia and atherothrombotic disease[J].Semin Thromb Hemost,1998,23 (4):381-385%.
7Golomb BA,Dimsdale JE,White HL,et al.Redaction in blood pressure with stating:results from the UCSD statin study,a randomized trial[J].Arch Intem Med,2008,168(7):721-727.
8BSchwartz GC,Olsson AG,Ezekowitz MD,et al.Effects of atorvastain on early recurrent ischemic events in acute coronary syndromtes:the MIRACL study:a randomized controlled trial[J].JAMA,2001,285(5):1711.
9Kostapanos MS,Milionis HJ,Elissf MS.An over view of the extra-lipid effects of rosuvastation[J].J Cardiovasc Pharmacol Ther,2008,13(3):157-174.
